Christopher Galloway
Family Medicine · Melbourne, FLNPI 1689619108
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $665 of the $1,009 with a category attached, or 66.0%. AstraZeneca accounts for 92.1% of it on its own, with 1 other manufacturer making up the rest.
Across 10 payments — averaging $100.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$929
- F. Hoffmann-la Roche AG$80
Across 1,895 payments — averaging $8244.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$3.1M
- Biogen$2.7M
- Janssen Research & Development, LLC$2.2M
- AstraZeneca$1.3M
- Merck$1.2M
- AbbVie$1.1M
- plus $4M from 17 others
What the payments were for
- Travel & lodging$66566%
- Food & beverage$34334%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $929 |
| F. Hoffmann-la Roche AG | 1 | $80 |
How this compares
$1,009 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Melbourne
- Frank DitzMelbourne$41K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.